Medicare expands coverage of lymphoedema devices
This article was originally published in Clinica
Medicare, the federal health plan for the elderly and disabled, is to expand its coverage of pneumatic compression devices used to treat patients with lymphoedema. The new coverage policy eliminates language that makes compression pumps the treatment of last resort for beneficiaries suffering from lymphoedema, which is an accumulation of lymphatic fluid causing abnormal swelling of the arms, legs, breast, neck or head that often develops when lymph nodes are removed during surgery. Breast cancer is the most common cause of the condition in the US.
You may also be interested in...
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.